Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results

Junwen Zhou, Aurélie Millier, Clément François, Samuel Aballéa, Mondher Toumi

Open source

DOI
10.1080/20016689.2019.1648973
Published
2019-01-01
Container
Journal of Market Access & Health Policy
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/20016689.2019.1648973,
  title = {Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results},
  author = {Junwen Zhou and Aurélie Millier and Clément François and Samuel Aballéa and Mondher Toumi},
  year = {2019},
  journal = {Journal of Market Access \& Health Policy},
  doi = {10.1080/20016689.2019.1648973},
  url = {https://doi.org/10.1080/20016689.2019.1648973}
}

RIS

TY  - JOUR
TI  - Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
AU  - Junwen Zhou
AU  - Aurélie Millier
AU  - Clément François
AU  - Samuel Aballéa
AU  - Mondher Toumi
PY  - 2019
JO  - Journal of Market Access & Health Policy
DO  - 10.1080/20016689.2019.1648973
UR  - https://doi.org/10.1080/20016689.2019.1648973
ER  - 

APA

Zhou, J., Millier, A., François, C., Aballéa, S., & Toumi, M. (2019). Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results. Journal of Market Access & Health Policy. https://doi.org/10.1080/20016689.2019.1648973

Source records